Literature DB >> 32213500

Successful remission with tofacitinib in a patient with refractory Takayasu arteritis complicated by ulcerative colitis.

Saki Kuwabara1, Shun Tanimura1, Shogo Matsumoto2, Hiroyuki Nakamura1, Tetsuya Horita3.   

Abstract

Entities:  

Keywords:  cytokines; giant cell arteritis; treatment

Mesh：

Substances：

Year:  2020        PMID： 32213500     DOI： 10.1136/annrheumdis-2019-216606

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   27.973


× No keyword cloud information.
  15 in total

1.  JAK-inhibition as a therapeutic strategy for refractory primary systemic vasculitides.

Authors:  Sujoy Khan
Journal:  Clin Med (Lond)       Date:  2021-03       Impact factor: 2.659

Review 2.  Pathogenesis and Treatment of T-Large Granular Lymphocytic Leukemia (T-LGLL) in the Setting of Rheumatic Disease.

Authors:  Nina Couette; Wael Jarjour; Jonathan E Brammer; Alexa Simon Meara
Journal:  Front Oncol       Date:  2022-06-07       Impact factor: 5.738

Review 3.  Characteristics of inflammatory bowel diseases in patients with concurrent immune-mediated inflammatory diseases.

Authors:  Shintaro Akiyama; Soma Fukuda; Joshua M Steinberg; Hideo Suzuki; Kiichiro Tsuchiya
Journal:  World J Gastroenterol       Date:  2022-07-07       Impact factor: 5.374

Review 4.  Large-vessel vasculitis.

Authors:  Dan Pugh; Maira Karabayas; Neil Basu; Maria C Cid; Ruchika Goel; Carl S Goodyear; Peter C Grayson; Stephen P McAdoo; Justin C Mason; Catherine Owen; Cornelia M Weyand; Taryn Youngstein; Neeraj Dhaun
Journal:  Nat Rev Dis Primers       Date:  2022-01-06       Impact factor: 65.038

Review 5.  Wind of Change in the Treatment of Childhood-Onset Takayasu Arteritis: a Systematic Review.

Authors:  Seher Sener; Ozge Basaran; Seza Ozen
Journal:  Curr Rheumatol Rep       Date:  2021-07-03       Impact factor: 4.592

Review 6.  An Update on Childhood-Onset Takayasu Arteritis.

Authors:  Florence A Aeschlimann; Rae S M Yeung; Ronald M Laxer
Journal:  Front Pediatr       Date:  2022-04-13       Impact factor: 3.569

Review 7.  A systematic review of clinical and preclinical evidences for Janus kinase inhibitors in large vessel vasculitis.

Authors:  Upendra Rathore; Darpan Radheshyam Thakare; Pallavi Patro; Vikas Agarwal; Aman Sharma; Durga Prasanna Misra
Journal:  Clin Rheumatol       Date:  2021-11-03       Impact factor: 3.650

Review 8.  Cellular Signaling Pathways in Medium and Large Vessel Vasculitis.

Authors:  Ryu Watanabe; Gerald J Berry; David H Liang; Jörg J Goronzy; Cornelia M Weyand
Journal:  Front Immunol       Date:  2020-09-25       Impact factor: 7.561

Review 9.  Innate and Adaptive Immunity in Giant Cell Arteritis.

Authors:  Mitsuhiro Akiyama; Shozo Ohtsuki; Gerald J Berry; David H Liang; Jörg J Goronzy; Cornelia M Weyand
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

Review 10.  Reducing the Toxicity of Long-Term Glucocorticoid Treatment in Large Vessel Vasculitis.

Authors:  Andriko Palmowski; Frank Buttgereit
Journal:  Curr Rheumatol Rep       Date:  2020-10-12       Impact factor: 4.592
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.